JW Pharmaceutical Corp. (formerly Choongwae Pharma) is one of the leading pharmaceutical companies in Korea with core competencies in antibiotics, IV solutions, and anti-cancer treatments. JW is currently exploring targeted therapies in oncology leveraging the collaborative research and development strengths from the JW Drug Discovery Center in Korea and the JW Theriac Corp in the US. This R&D pipeline is driven by our platform technologies that have the potential to eradicate cancer stem cells selectively through a molecularly targeted approach.
The order this company entered each market — oldest to newest
JW Pharmaceutical: ITP drug shows 36% platelet response
JW Pharmaceutical attends JPMHC 2026, discusses global partnerships
Sign up to see the full signal feed
How JW Pharmaceutical Corporation's international expansion compares to its competitors
JW Pharmaceutical CorporationYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 JW Pharmaceutical CorporationYou | 0 | 0 | 0% | 0 | 10 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
JW Pharmaceutical held a symposium for its colon cleanser 'Jeacle Tablet', sharing clinical data on efficacy, safety, and patient compliance. The product requires only 20 tablets and achieved 97% cleansing rate.
JW Pharmaceutical launches Livarohigh, Korea's first 3-in-1 drug combining pitavastatin, amlodipine, and valsartan to treat hypertension and dyslipidemia simultaneously.
JW Pharmaceutical's gout treatment drug Epaminurad received a US patent, extending market exclusivity to 2038. Chong Kun Dang presented preclinical results for a neurodegenerative disease treatment. Boryung held an award ceremony for medical essays.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about JW Pharmaceutical Corporation's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
